Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has appointed MDL Asia Pty Ltd (“MDL” or “MDL Asia”) as its marketing and distribution partner in the Asia Pacific region, excluding Greater China. Download press release
Visit PageNews and Events
Novacyt Named in Deloitte Technology Fast 500
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release
Visit PageNovacyt Named in Deloitte Technology Fast 50
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 50 in France. Download press release
Visit PageNovacyt appoints Anthony Dyer as Finance Director
Novacyt (Mmemo: ALNOV – FR0010397232) announces that Anthony Dyer will become Finance Director. Download press release
Visit PageNovacyt strengthens board
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics is pleased to announce the addition of new members to its Board as the Company prepares for the next stages of growth. Download press release
Visit PageNovacyt appoints new Group Commercial Director
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release
Visit Page